These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1956918)

  • 21. The health risk of nitrosamines with Gerhard Eisenbrand.
    Eisenbrand G
    Mol Nutr Food Res; 2005 Mar; 49(3):226-7. PubMed ID: 15744715
    [No Abstract]   [Full Text] [Related]  

  • 22. Preformed N-nitroso compounds in foods and beverages.
    Hotchkiss JH
    Cancer Surv; 1989; 8(2):295-321. PubMed ID: 2696582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA dosimetry following carcinogen exposure using accelerator mass spectrometry and 32P-postlabeling.
    Felton JS; Turteltaub KW; Gledhill BL; Vogel JS; Buonarati MH; Davis JC
    Prog Clin Biol Res; 1991; 372():243-53. PubMed ID: 1956922
    [No Abstract]   [Full Text] [Related]  

  • 24. DNA adducts and the mechanism of carcinogenesis and cytotoxicity of methylating agents of environmental and clinical significance.
    Kyrtopoulos SA; Anderson LM; Chhabra SK; Souliotis VL; Pletsa V; Valavanis C; Georgiadis P
    Cancer Detect Prev; 1997; 21(5):391-405. PubMed ID: 9307842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats.
    Trushin N; Hecht SS
    Chem Res Toxicol; 1999 Feb; 12(2):164-71. PubMed ID: 10027794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative structure-carcinogenicity relationship for detecting structural alerts in nitroso compounds: species, rat; sex, female; route of administration, gavage.
    Morales Helguera A; Pérez González M; Dias Soeiro Cordeiro MN; Cabrera Pérez MA
    Chem Res Toxicol; 2008 Mar; 21(3):633-42. PubMed ID: 18293904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring endogenous nitrosamine formation in man.
    Ohshima H; Bartsch H
    IARC Sci Publ; 1984; (59):233-46. PubMed ID: 6545281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Environmental exposure to preformed nitroso compounds.
    Tricker AR; Spiegelhalder B; Preussmann R
    Cancer Surv; 1989; 8(2):251-72. PubMed ID: 2696580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids.
    Tricker AR
    Eur J Cancer Prev; 1997 Jun; 6(3):226-68. PubMed ID: 9306073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [THE EFFECT OF CARCINOGENIC NITROSAMINE AND NITROSAMIDE ON THE ADENINE-6-45 REVERSE MUTATION SYSTEM OF SACCHAROMYCES CEREVISIAE].
    MARQUARDT H; ZIMMERMANN FK; SCHWAIER R
    Z Vererbungsl; 1964 Apr; 95():82-96. PubMed ID: 14196023
    [No Abstract]   [Full Text] [Related]  

  • 31. [Transplacental blastomogenic effect of dimethyl nitrosamine and nitrosomethyl urea].
    Smetanin EE
    Vopr Onkol; 1971; 17(8):75-81. PubMed ID: 5134102
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical laboratory evaluation of potential reduced exposure products for smokers.
    Breland AB; Kleykamp BA; Eissenberg T
    Nicotine Tob Res; 2006 Dec; 8(6):727-38. PubMed ID: 17132520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Markers of the formation of carcinogenic nitroso compounds].
    Rubenchik BL
    Vopr Onkol; 1987; 33(7):3-9. PubMed ID: 3303683
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of the intake of a nitrosatable drug on the nitrosamine levels in human urine.
    Webb KS; Wood BJ; Gough TA
    J Anal Toxicol; 1983; 7(4):181-4. PubMed ID: 6632801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transnitrosating activity of N-nitroso-N-methyl-p-toluenesulfonamide in rats and human gastric juice.
    Börzsönyi M; Sajgó K; Török G; Pintér A; Tamás J; Kolar G; Spiegelhalder B
    Neoplasma; 1988; 35(3):257-62. PubMed ID: 3405334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA damage studies related to the assessment of the role of N-nitroso compounds in human cancer.
    Kyrtopoulos SA; Souliotis VL; Chhabra SK; Anderson LM
    Eur J Cancer Prev; 1996 Sep; 5 Suppl 1():109-14. PubMed ID: 8972304
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemical and molecular effects of N-nitroso compounds in human cultured cells: an overview.
    Harris CC
    IARC Sci Publ; 1987; (84):20-5. PubMed ID: 3315996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some N-nitrosamines derived from areca-nut alkaloids.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1985 Sep; 37():263-8. PubMed ID: 3866746
    [No Abstract]   [Full Text] [Related]  

  • 39. A review: dietary and endogenously formed N-nitroso compounds and risk of childhood brain tumors.
    Dietrich M; Block G; Pogoda JM; Buffler P; Hecht S; Preston-Martin S
    Cancer Causes Control; 2005 Aug; 16(6):619-35. PubMed ID: 16049800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological assessment of risk to humans from exposure to nitrosamines.
    Miller AB; Choi BC; Howe GR; Burch JD; Sherman GJ
    IARC Sci Publ; 1984; (57):929-36. PubMed ID: 6533077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.